home / stock / vm:cc / vm:cc news

VM:CC News and Press, Voyageur Pharmaceuticals Ltd. From 02/05/25

Stock Information
Company Name: Voyageur Pharmaceuticals Ltd.
Stock Symbol: VM:CC
Market: TSXVC
Website: voyageurpharmaceuticals.ca
Menu
VM:CC VM:CC Quote VM:CC Short VM:CC News VM:CC Articles VM:CC Message Board
Get VM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
VM:CC - Voyageur Receives $600K Grant from Alberta Innovates for Product Development

(TheNewswire) Voyageur receives $600,000 in funding through Alberta Innovates AICE-Market Access Program Calgary, Alberta, Canada – February 5, 2025 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“ Voyageur &#x...
VM:CC - Voyageur Secures $687k of Additional Capital from Warrant Exercises

(TheNewswire) Voyageur streamlines capitalization table through exercise of 5,725,829 warrants, expiry of 8,844,935 warrants Strong existing shareholder support, raising gross proceeds of $687,099 Calgary, Alberta, Canada – January 23, 2025 –...

VM:CC - Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite

(TheNewswire) LOI with Multinational Contrast Media Company Voyageur Introduced Five New Health Canada Licensed Barium Contrast Products Securing 1st Sales Contract Calgary, Alberta, Canada – TheNewswire - January 1 5 , 2025 - V...

VM:CC - Voyageur Commences Testing of Innovative Barium Contrast Product Line in Human Radiology Scans, Paving the Way for Near-Term Market Launch

(TheNewswire) Calgary, Alberta, Canada – TheNewswire - January 13, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (" Voyageur " or the " Company ") is pleased to announce that it has begun human testing on its latest barium contrast suite of ...
Previous 10 Next 10